Compare Smith & Nephew plc (SNN) vs Trip.com Group Ltd (TCOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Trip.com Group Ltd — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while Trip.com Group Ltd trades at $43.78 (market cap $28.12B). The key difference: Trip.com Group Ltd is far larger — about 2.2× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.57%). Which is the better fit depends on your goals.
| SNN | TCOM | |
|---|---|---|
Market Cap | $12.64B | $28.12B |
Sector | Health | Consumer Cyclical |
52-Week High | $38.70 | $78.96 |
52-Week Low | $28.73 | $39.84 |
Enterprise Value | $15.41B | $20.82B |
Dividend Yield | 2.57% | 0.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Trip.com Group (TCOM) trades at $43.65, up 2.83% with strong fundamentals including a 6.64 P/E ratio and 48.65% net margin. Recent Q1 2026 earnings missed expectations at $0.83 per share versus $0.85 expected, though revenue grew 17% year-over-year. Technical indicators show a bullish overall signal with resistance near $45, while news highlights institutional buying and regulatory scrutiny concerns.
The outlook remains positive with a $56.72 analyst price target implying 30% upside, supported by robust cash flow and expanding profitability. Key risks include Q2 revenue guidance of 3%-8% growth lagging expectations and ongoing antitrust investigations in China that could pressure margins near-term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Trip.com Group Ltd
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Prior to the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from websites and mobile platforms, while the rest come from call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Toncheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
Read more on TCOM →
